Jennison Associates
COLL icon

Jennison Associates’s Collegium Pharmaceutical COLL Stock Holding History

Jennison Associates’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
28,636
+8,200
+40% +$280K ﹤0.01% 497
2026
Q1 		$676K Buy
+20,436
New +$865K ﹤0.01% 529

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jennison Associates's COLL Position: Q2 2026 in Review

Jennison Associates increased its Collegium Pharmaceutical (COLL) stake by 40% in Q2 2026, buying an estimated $280K and bringing the position to 28,636 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #497.

Jennison Associates first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Jennison Associates held 28,636 shares of Collegium Pharmaceutical worth $1.04M as of Q2 2026.
  • Jennison Associates bought 8,200 Collegium Pharmaceutical shares in Q2 2026, an estimated $280K.
  • Collegium Pharmaceutical made up ﹤0.01% of Jennison Associates's portfolio in Q2 2026, its #497 holding.
  • Jennison Associates first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.